Strides Arcolab in pact with Brazil based companyIllustrative image – not actual.

Agila Specialties, the subsidiary of Strides Arcolab, on 20 January 2011 signed a JV agreement with Brazil based BioChimico Industria Farmaceutica.

The agreement has been signed for starting a Brazil based JV with BioChimico, to enter the hospital-based anaesthetics and high-end injections segment. Agila will hold 52 per cent equity in the venture. However, investment details of the venture have not been disclosed.

The products are to be manufactured at Strides' Brazil based facility in Campos, and BioChimico's two plants in Rio de Janeiro and Itatiaia, on a pre-determined cost model and transferred to the new venture for distribution.

Both the partners are expected to transfer selected Brazilian intellectual properties to the new company to enable joint marketing.

← All latest storiesBack to top →